ERBB2 and breast cancer: BC represents a heterogeneous disease, characterized by the presence versus absence of specific receptors on the tumor cells: hormonal receptors (HR) (estrogen receptors (ER) and progesterone receptors (PR)) and human epidermal growth factor receptor 2 (HER2) [20].